Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Biotech
Omeros stock up after data analysis spurs BLA resubmission plan
Given the results, Omeros hopes the anti-MASP-2 antibody narsoplimab will become the first treatment on the market in the indication.
Gabrielle Masson
Dec 19, 2024 10:54am
VC firm pens $608M deal to direct NGM MASH drug to rare disease
Dec 19, 2024 10:30am
Artivion nets FDA greenlight for aortic tear implant
Dec 10, 2024 1:30pm
FDA chides Applied Therapeutics' trial conduct in warning letter
Dec 4, 2024 11:21am
FDA rejects Applied filing for rare disease approval
Dec 2, 2024 5:27am
Plant compound restores sensation in mice with nerve disorder
Nov 20, 2024 2:30pm
